|
Volumn 23, Issue 2, 2013, Pages 503-506
|
2′-Fluoro-6′-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: In vitro anti-HBV activity against the lamivudine-entecavir resistant triple mutant and its mechanism of action
|
Author keywords
Anti HBV activity; Carbocyclic nucleos(t)ide; Drug resistant mutants; Lamivudine entecavir triple mutant; Wild type
|
Indexed keywords
2' FLUORO 6' METHYLENE CARBOCYCLIC ADENOSINE;
2' FLUORO 6' METHYLENE CARBOCYCLIC ADENOSINE MONOPHOSPHATE;
ANTIVIRUS AGENT;
ENTECAVIR;
LAMIVUDINE;
PHOSPHORAMIDIC ACID DERIVATIVE;
UNCLASSIFIED DRUG;
2' FLUORO 6' METHYLENE CARBOCYCLIC ADENOSINE PHOSPHORAMIDATE;
2'-FLUORO-6'-METHYLENE-CARBOCYCLIC ADENOSINE;
2'-FLUORO-6'-METHYLENE-CARBOCYCLIC ADENOSINE PHOSPHORAMIDATE;
ADENOSINE;
DRUG DERIVATIVE;
GUANINE;
PRODRUG;
ANTIVIRAL ACTIVITY;
ANTIVIRAL RESISTANCE;
ARTICLE;
CHEMICAL REACTION;
CYTOTOXICITY;
DRUG BINDING;
DRUG SYNTHESIS;
HEPATITIS B;
HEPATITIS B VIRUS;
HYDROGEN BOND;
NONHUMAN;
VAN DER WAALS INTERACTION;
BINDING SITE;
CELL CULTURE;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG EFFECT;
GENETICS;
HUMAN;
IC 50;
MUTATION;
SYNTHESIS;
THERMODYNAMICS;
HEPATITIS B VIRUS;
ADENOSINE;
ANTIVIRAL AGENTS;
BINDING SITES;
CELLS, CULTURED;
DRUG RESISTANCE, VIRAL;
GUANINE;
HEPATITIS B VIRUS;
HUMANS;
HYDROGEN BONDING;
INHIBITORY CONCENTRATION 50;
LAMIVUDINE;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
MUTATION;
PRODRUGS;
THERMODYNAMICS;
|
EID: 84871717179
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.11.027 Document Type: Article |
Times cited : (17)
|
References (21)
|